Cargando…
Safeguarding evidence-based decision making in the FDA for COVID-19 vaccines
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7983546/ https://www.ncbi.nlm.nih.gov/pubmed/33785254 http://dx.doi.org/10.1016/j.vaccine.2021.03.053 |
| _version_ | 1783667925878571008 |
|---|---|
| author | Angelis, Aris Darrow, Jonathan |
| author_facet | Angelis, Aris Darrow, Jonathan |
| author_sort | Angelis, Aris |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7983546 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-79835462021-03-23 Safeguarding evidence-based decision making in the FDA for COVID-19 vaccines Angelis, Aris Darrow, Jonathan Vaccine Commentary Elsevier Ltd. 2021-04-22 2021-03-22 /pmc/articles/PMC7983546/ /pubmed/33785254 http://dx.doi.org/10.1016/j.vaccine.2021.03.053 Text en © 2021 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Commentary Angelis, Aris Darrow, Jonathan Safeguarding evidence-based decision making in the FDA for COVID-19 vaccines |
| title | Safeguarding evidence-based decision making in the FDA for COVID-19 vaccines |
| title_full | Safeguarding evidence-based decision making in the FDA for COVID-19 vaccines |
| title_fullStr | Safeguarding evidence-based decision making in the FDA for COVID-19 vaccines |
| title_full_unstemmed | Safeguarding evidence-based decision making in the FDA for COVID-19 vaccines |
| title_short | Safeguarding evidence-based decision making in the FDA for COVID-19 vaccines |
| title_sort | safeguarding evidence-based decision making in the fda for covid-19 vaccines |
| topic | Commentary |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7983546/ https://www.ncbi.nlm.nih.gov/pubmed/33785254 http://dx.doi.org/10.1016/j.vaccine.2021.03.053 |
| work_keys_str_mv | AT angelisaris safeguardingevidencebaseddecisionmakinginthefdaforcovid19vaccines AT darrowjonathan safeguardingevidencebaseddecisionmakinginthefdaforcovid19vaccines |